trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['fam-trastuzumab', 'trastuzumab deruxtecan', 'bcsm', 'breast']
treatment with fam-trastuzumab deruxtecan-nxki yielded promising patient-reported outcomes in patients with hormone receptor positive, her2-low metastatic breast cancer. #bcsm #esmo22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.